Plasma or serum samples: measurements of cardiac troponin T and of other analytes compared
-
Roberto Dominici
Abstract
Conflicting data in the literature concern possible differences in the immunochemical measurement of cardiac troponins, either in plasma or in serum. In order to address this specific point, 96 serum and heparin-plasma pairs were obtained for cardiac marker measurement [cardiac troponin T (cTnT); myoglobin (Myo) and creatine kinase-MB isoenzyme (CK-MB)]; 29 additional “common” analytes were measured in 77 such samples. The cardiac markers were measured by electrochemiluminescence (Elecsys 2010, Roche); the other analytes by established automated methods (Modular, Roche). Mean plasma/serum ratios for cTnT (0.95), creatine kinase-MB (1.01) and myoglobin (0.99) were comparable with those of the 29 common analytes (interval of means 0.83–1.05). The distribution of the plasma-serum differences also showed similarities between cardiac markers and other analytes. A few outlier plasma-serum differences (3–5%) were measured for both categories of analytes. Addition of heparin to serum (51 samples) caused decreased cTnT (mean ratio 0.92). In 3 of 51 such samples the cTnT decrease was more marked, but in a second sample from the same subjects (1 week later) such a prominent, heparin-induced loss of cTnT no longer appeared. In conclusion, plasma-serum differences in immuno-reactive cTnT compare with those observed for other analytes. In occasional heparin-plasma samples immunochemical measurement of cTnT may give exceptionally low values. However, in our sample group of 96 patients (cTnT lower or higher than the cut-off in, respectively, 24 and 72 patients), no misclassification occurred if plasma instead of serum cTnT values were considered.
References
1 Panteghini M. IFCC Committee on Standardization of Markers of Cardiac Damage: premises and project presentation. Clin Chem Lab Med 1998; 36:887–93.10.1515/CCLM.1998.155Search in Google Scholar
2 Panteghini M, Apple FS, Christenson RH, Dati F, Mair J, Wu AH. Use of biochemical markers in acute coronary syndromes. Clin Chem Lab Med 1999; 37:687–93.10.1515/CCLM.1999.107Search in Google Scholar
3 Nosanchuk JS. False increase of troponin I attributable to incomplete separation of serum [letter]. Clin Chem 1999; 45:714.10.1093/clinchem/45.5.714Search in Google Scholar
4 Wu AHB, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999; 45:1104–21.10.1093/clinchem/45.7.1104Search in Google Scholar
5 Gerhardt W, Nordin G, Herbert A-K, Burzell BL, Isaksson A, Gustavsson E, et al. Troponin T and I assays show decreased concentrations in heparin plasma compared with serum: lower recoveries in early than in late phases of myocardial injury. Clin Chem 2000; 46:817–21.10.1093/clinchem/46.6.817Search in Google Scholar
6 Stiegler H, Fischer Y, Vazquez-Jimenez JF, Graf J, Filzmaier K, Fausten B, et al. Lower cardiac troponin T and I results in heparin-plasma than in serum. Clin Chem 2000; 46:1338–44.10.1093/clinchem/46.9.1338Search in Google Scholar
7 Panteghini M. Present issues in the determination of troponins and other cardiac markers of cardiac damage. Clin Biochem 2000; 33:161–6.10.1016/S0009-9120(00)00063-1Search in Google Scholar
8 Pagani F, Bonetti G, Stefini F, Ciccia C, Panteghini M. Serum and plasma samples for ACS:systems cardiac markers [letter]. Clin Chem 2000; 46:1020–2.10.1093/clinchem/46.7.1020Search in Google Scholar
9 Hedberg P, Melkko T, Valkama J, Puukka M. Higher CK-MB mass values in heparin plasma than in serum measured with the Abbott AxSYM system [letter]. Clin Chem Lab Med 2001; 39:872–4.10.1515/CCLM.2001.144Search in Google Scholar PubMed
10 Buechler KF, Nakamura KK. More on troponin assays and heparin [letter]. Clin Chem 2001; 47:144–7.10.1093/clinchem/47.1.144Search in Google Scholar
11 Gerhardt W, Nordin G, Isaksson A, Haglund S, Gustavsson S, Muller-Bardof M, et al. More on troponin assays and heparin [reply letter]. Clin Chem 2001; 47:145–7.Search in Google Scholar
12 Cerutti A, Corsini L, Finotto R, Perazzi C. Comparison of cardiac troponin I in serum and heparin plasma with the dimension RxL assay. Clin Chem 2002; 48:790–1.10.1093/clinchem/48.5.790Search in Google Scholar
13 Penttila K, Koukkunen H, Halinen M, Punnonen K, Pyirala K, Rantanen T, et al. Serum and plasma as alternative sample types in analysis of cardiac markers in the clinical routine. Scand J Clin Lab Invest 2002; 62:553–60.10.1080/003655102321004576Search in Google Scholar PubMed
14 Panteghini M. Performance of today’s cardiac troponin assays and tomorrow’s. Clin Chem 2002; 48:809–10.10.1093/clinchem/48.6.809Search in Google Scholar
15 Peetz D, Hafner G, Lackner KJ. Analytical characteristics of the AxSYM troponin I and creatine kinase MB assays. Clin Chem 2002; 48:1110–1.10.1093/clinchem/48.7.1110Search in Google Scholar
16 Dorizzi RM, Caputo M, Ferrari A, Lippi L, Rizzotti P. Comparison of serum and heparin-plasma samples in different generations of dimension troponin I assays [letter]. Clin Chem 2003; 49:2294–5.Search in Google Scholar
17 Panteghini M, Pagani F. On the comparison of serum and plasma samples in troponin assays [letter]. Clin Chem 2003; 49:835–6.10.1373/49.5.835/-aSearch in Google Scholar PubMed
18 Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Applications of linear regression procedures for method comparison studies in clinical chemistry. Part I. J Clin Chem Clin Biochem 1983; 21:709–20.Search in Google Scholar
19 Fraser CG, Hyltoft Petersen P. Analytical performance characteristics should be judged against objective quality specifications. Clin Chem 1999; 45:321–3.10.1093/clinchem/45.3.321Search in Google Scholar
20 Ciuti R, Rinaldi G. Serum and plasma compared for use in 19 common chemical tests performed in the Hitachi 737 analyzer [letter]. Clin Chem 1989; 35:1562–3.10.1093/clinchem/35.7.1562Search in Google Scholar
21 Doumas BT, Hause LL, Simuncak DM, Breitenfeld D. Differences between values for plasma and serum in tests performed in the Ektachem 700 XR analyzer, and evaluation of ‘‘plasma separator tubes (PST)’’. Clin Chem 1989; 35:151–3.10.1093/clinchem/35.1.151Search in Google Scholar
22 Dupuy AM, Badiou S, Descomps B, Cristol JP. Immunoturbidimetric determination of C-reactive protein (CRP) on heparin plasma. Comparison with serum determination. Clin Chem Lab Med 2003; 41:948–9.Search in Google Scholar
23 Cloete H, Kleinhans W, Mansvelt EPG. Ferritin assay performed on the Technicon Immuno 1 analyser using serum and plasma samples. Clin Lab Haem 2002; 24:281–3.10.1046/j.1365-2257.2002.00469.xSearch in Google Scholar PubMed
24 Hartland AJ, Neary RH. Serum potassium is unreliable as an estimate of in vivo plasma potassium. Clin Chem 1999; 45:1091–2.10.1093/clinchem/45.7.1091Search in Google Scholar
25 Bakker AJ, Mirchi B, Dijkstra JT, Reitsma F, Syperda H, Zijlstra A. IFCC method for lactate dehydrogenase measurement in heparin plasma is unreliable [technical briefs]. Clin Chem 2003; 49:662–4.10.1373/49.4.662Search in Google Scholar
26 Herzum I, Bander R, Renz H, Wahl HG. Reliability of IFCC method for lactate dehydrogenase measurement in lithium-heparin plasma samples. Clin Chem 2003; 49:2094–6.10.1373/clinchem.2003.026336Search in Google Scholar
27 Panteghini M, Pagani F. Biological variation of myoglobin in serum [letter]. Clin Chem 1997; 43:2435.10.1093/clinchem/43.12.2435Search in Google Scholar
28 Ross SM, Fraser CG. Biological variation of cardiac markers: analytical and clinical considerations. Ann Clin Biochem 1998; 35:80–4.10.1177/000456329803500110Search in Google Scholar
29 Speth M, Seibold K, Katz N. Interaction between heparin and cardiac troponin T and troponin I from patients after coronary bypass surgery. Clin Biochem 2002; 35:355–62.10.1016/S0009-9120(02)00328-4Search in Google Scholar
30 Eriksson S, Junikka M, Laitinen P, Majamaa-Voltti K, Alfthan H, Pettersson K. Negative interference in cardiac troponin I immunoassays from a frequently occurring serum and plasma component. Clin Chem 2003; 49:1095–104.10.1373/49.7.1095Search in Google Scholar PubMed
31 Bhagavan NV, Lai EM, Rios PA, Yang J, Ortega-Lopez AM, Shinoda H, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 2003; 49:581–5.10.1373/49.4.581Search in Google Scholar PubMed
32 Apple FS, Quist HE, Doyle PJ, Otto AP, Murakami MM. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem 2003; 49:1331–6.10.1373/49.8.1331Search in Google Scholar PubMed
© Walter de Gruyter
Articles in the same Issue
- Rapid detection of the factor XIII Val34Leu (163 G→T) polymorphism by real-time PCR using fluorescence resonance energy transfer detection and melting curve analysis
- Changes of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in the serum of patients with autoimmune diseases: association with age and disease activity
- A recombinant cell bioassay for measurement of overall estrogenic activity of serum: preliminary results in women with breast cancer
- N-terminal pro-atrial natriuretic peptide as a biochemical marker of long-term interventional success after radiofrequency catheter ablation of paroxysmal supraventricular tachyarrhythmias
- Preventing in vitro lipoperoxidation in the malondialdehyde-thiobarbituric assay
- Oxidative stress: potential of distinct peroxide determination systems
- Quality assessment in cytogenetic and molecular genetic testing: the experience of the Italian Project on Standardisation and Quality Assurance
- Guidelines for blood smear preparation and staining procedure for setting up an external quality assessment scheme for blood smear interpretation. Part I: control material
- Measurement of serum and plasma osmolality in healthy young humans – influence of time and storage conditions
- High in-hospital mortality of intensive care patients with nucleated red blood cells in blood
- Frequency of –163 C > A and 63 C > G single nucleotide polymorphism of cytochrome P450 1A2 in two African populations
- Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples
- Plasma or serum samples: measurements of cardiac troponin T and of other analytes compared
- Antioxidant capacity of the human pericardial fluid: does gender have a role?
- Comparison of serum digoxin concentration monitoring by fluorescence polarization immunoassay on the TDxFLx® and dry chemistry enzyme immunoassay on the Vitros 950
- Multicenter analytical performance evaluation of the Elecsys® proBNP assay
- Analytical evaluation and reference values of serum amyloid-A on the BN ProSpec
- Reference values of soluble interleukin-2 receptor on the IMMULITE
- Analysis of cystatin C, creatinine, albumin, lipids and lipoprotein concentrations in serum and acidified citrate plasma (Stabilyte™) tubes compared
- Analysis of γ-globulins consisting of hepatitis C-associated cryoglobulins in the blood
- Serum total glutathione-S-transferase in stroke, a preliminary report
- Santorini Biologie Prospective Conference 2004 “From Human Genetic Variations to Prediction of Risks and Responses to the Environment”, Santorini, Greece, September 30–October 4, 2004
Articles in the same Issue
- Rapid detection of the factor XIII Val34Leu (163 G→T) polymorphism by real-time PCR using fluorescence resonance energy transfer detection and melting curve analysis
- Changes of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in the serum of patients with autoimmune diseases: association with age and disease activity
- A recombinant cell bioassay for measurement of overall estrogenic activity of serum: preliminary results in women with breast cancer
- N-terminal pro-atrial natriuretic peptide as a biochemical marker of long-term interventional success after radiofrequency catheter ablation of paroxysmal supraventricular tachyarrhythmias
- Preventing in vitro lipoperoxidation in the malondialdehyde-thiobarbituric assay
- Oxidative stress: potential of distinct peroxide determination systems
- Quality assessment in cytogenetic and molecular genetic testing: the experience of the Italian Project on Standardisation and Quality Assurance
- Guidelines for blood smear preparation and staining procedure for setting up an external quality assessment scheme for blood smear interpretation. Part I: control material
- Measurement of serum and plasma osmolality in healthy young humans – influence of time and storage conditions
- High in-hospital mortality of intensive care patients with nucleated red blood cells in blood
- Frequency of –163 C > A and 63 C > G single nucleotide polymorphism of cytochrome P450 1A2 in two African populations
- Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples
- Plasma or serum samples: measurements of cardiac troponin T and of other analytes compared
- Antioxidant capacity of the human pericardial fluid: does gender have a role?
- Comparison of serum digoxin concentration monitoring by fluorescence polarization immunoassay on the TDxFLx® and dry chemistry enzyme immunoassay on the Vitros 950
- Multicenter analytical performance evaluation of the Elecsys® proBNP assay
- Analytical evaluation and reference values of serum amyloid-A on the BN ProSpec
- Reference values of soluble interleukin-2 receptor on the IMMULITE
- Analysis of cystatin C, creatinine, albumin, lipids and lipoprotein concentrations in serum and acidified citrate plasma (Stabilyte™) tubes compared
- Analysis of γ-globulins consisting of hepatitis C-associated cryoglobulins in the blood
- Serum total glutathione-S-transferase in stroke, a preliminary report
- Santorini Biologie Prospective Conference 2004 “From Human Genetic Variations to Prediction of Risks and Responses to the Environment”, Santorini, Greece, September 30–October 4, 2004
